- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04342338
Pharmacist and Family Medicine Physician Collaboration for Pre-Visit Planning and Team Huddles for CCM Patients
August 28, 2020 updated by: Northeast Iowa Medical Education Foundation
Pharmacist and Family Medicine Physician Collaboration for Pre-Visit Planning and Team Huddles for Patients Receiving Chronic Care Management Services
This is a novel project which incorporates clinic and community pharmacists in three aspects of the Patient-Centered Medical Home: pre-visit planning, pre-visit care team huddles, and chronic care management (CCM).
Patients for the project are enrolled in the NEIFPC CCM program and have Greenwood pharmacy as their primary pharmacy.
Community and clinic pharmacists will contribute to pre-visit medication reviews and document their drug therapy recommendations in a shared, templated note in the clinic EHR.
NEIFPC pharmacists will attend pre-visit team huddles to relay drug therapy recommendations to the physician.
Revenue from CCM services will be prorated and shared between Greenwood pharmacy and NEIFPC.
The project will last 9 months.
Primary aims are to describe the pharmacist pre-visit planning service, summarize the billing experience of a community pharmacist providing this service, and to describe the drug therapy interventions made by pharmacists.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Iowa
-
Waterloo, Iowa, United States, 50702
- Northeast Iowa Family Practice
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Medicare patient's who are enrolled in the CCM program at the Northeast Iowa Family Practice Center with Greenwood Pharmacy as their primary pharmacy.
Description
Inclusion Criteria:
- Patient enrolled in Medicare
- Patient enrolled in the Chronic Care Management (CCM) program at the Northeast Iowa Family Practice Center
- Patient's primary pharmacy is Greenwood Pharmacy
Exclusion Criteria:
- Patient not enrolled in Medicare
- Patient not enrolled in CCM program
- Patient's primary pharmacy is any pharmacy other than Greenwood Pharmacy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Summary of Drug Therapy Interventions made by Pharmacists
Time Frame: 07/01/2020- 03/31/2021
|
Summarize drug therapy interventions made by community and ambulatory care pharmacists for pre-visit team huddles with Family Medicine physicians.
|
07/01/2020- 03/31/2021
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 3, 2020
Primary Completion (Anticipated)
April 30, 2021
Study Completion (Anticipated)
April 30, 2021
Study Registration Dates
First Submitted
April 8, 2020
First Submitted That Met QC Criteria
April 8, 2020
First Posted (Actual)
April 13, 2020
Study Record Updates
Last Update Posted (Actual)
September 1, 2020
Last Update Submitted That Met QC Criteria
August 28, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Conditions, Multiple
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
Children's Hospital Los AngelesOrganonRecruitingChronic Conditions, MultipleUnited States
-
Documenting Hope ProjectRecruiting
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsActive, not recruitingChronic Conditions, Multiple | Chronic ConditionDenmark
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)RecruitingChronic Conditions, MultipleUnited States
-
Radboud University Medical CenterRecruiting
-
University of Colorado, DenverNational Institute on Aging (NIA)CompletedChronic Conditions, MultipleUnited States
-
Innovation Research & TrainingCompletedHealthy | Chronic Illnesses, MultipleUnited States
-
Universidad de AlmeriaTorrecárdenas Hospital; Almería Health DistrictCompleted